Lv41
478 积分 2024-01-24 加入
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
3小时前
待确认
Once-Weekly Semaglutide in Adults with Overweight or Obesity
4小时前
已完结
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
5小时前
已完结
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
5小时前
已完结
Lean Mass Changes With Incretin Therapy Versus Lifestyle Intervention: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials
5小时前
已完结
Comparative efficacy and safety of glucagon-like peptide 1 based drugs for weight loss in adults with overweight or obesity without diabetes: network meta-analysis of randomised controlled trials
5小时前
已完结
Current pharmacotherapy for obesity
14天前
已完结
Anti-obesity therapy with peripheral CB1 blockers: from promise to safe(?) practice
14天前
已完结
Anti-obesity drug discovery: advances and challenges
14天前
已完结
Controversies surrounding peripheral cannabinoid receptor 1 in fatty liver disease
1个月前
已完结
皖公网安备34019202002308
